Nicoderm cq and Ritalin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nicoderm cq (nicotine) and Ritalin (methylphenidate hydrochloride). Common drug interactions include anxiety among females and abdominal pain upper among males.
The phase IV clinical study analyzes what interactions people have when they take Nicoderm cq and Ritalin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Nicoderm cq?
Nicoderm cq has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 18,564 Nicoderm cq users. Check the latest studies of Nicoderm cq.
What is Ritalin?
Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.
19 people who take Nicoderm cq and Ritalin together, and have interactions are studied.

What are the common drug interactions of Nicoderm Cq and Ritalin, by gender? *:
female:
- Anxiety
- Contusion (a type of hematoma of tissue in which capillaries)
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Drug ineffective
- Muscle spasms (muscle contraction)
- Rectal haemorrhage (bleeding from anus)
- Swelling
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Palpitations (feelings or sensations that your heart is pounding or racing)
male:
- Abdominal pain upper
- Abnormal behaviour
- Decreased appetite
- Depressed mood
- Dysthymic disorder (mild chronic depression disorder)
- Eyeball avulsion (eyeball injury(eyeball away from the main mass of bone))
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Malaise (a feeling of general discomfort or uneasiness)
- Medical device pain (pain due to medical device)
What are the common drug interactions of Nicoderm Cq and Ritalin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Weight decreased
30-39:
- Abnormal behaviour
- Anger
- Anxiety
- Dysthymic disorder (mild chronic depression disorder)
- Personality disorder
- Suicidal ideation
40-49:
- Pneumonia
- Pyrexia (fever)
- Scar
- Chest pain
- Cough
- Dyspnoea (difficult or laboured respiration)
- Lung disorder (lung disease)
- Pleural effusion (water on the lungs)
50-59:
- Non-cardiac chest pain
- Asthenia (weakness)
- Cellulitis (infection under the skin)
- Chest pain
- Fall
60+:
n/a
What are the existing conditions these people have? *
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 68.42%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 68.42%
- Swelling: 4 people, 21.05%
- Stress And Anxiety: 4 people, 21.05%
- Nausea (feeling of having an urge to vomit): 3 people, 15.79%
- Vitamin D Decreased: 2 people, 10.53%
- Depression: 2 people, 10.53%
- Fatigue (feeling of tiredness): 2 people, 10.53%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.53%
- Headache (pain in head): 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Nicoderm cq and Ritalin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Nicoderm cq (18,564 reports)
- Ritalin (29,427 reports)
Browse all drug interactions of Nicoderm cq and Ritalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nicoderm cq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ritalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nicoderm cq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ritalin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on nicotine and methylphenidate hydrochloride (the active ingredients of Nicoderm cq and Ritalin, respectively), and Nicoderm cq and Ritalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Ziac and Avelox - a second ago
- Drug interactions of Paxlovid and Primidone - 2 seconds ago
- Sulfasalazine and Excessive Sleepiness for Men aged 40-49 - 12 seconds ago
- Sulfasalazine and Sleep - Too Much for Men aged 40-49 - 12 seconds ago
- Sulfasalazine and Sleep Disorders for Men aged 40-49 - 13 seconds ago
- Sulfasalazine and Sleep Disorder Therapy for Men aged 40-49 - 13 seconds ago
- Sulfasalazine and Sleep Disorder Due To General Medical Condition, Insomnia Type for Men aged 40-49 - 13 seconds ago
- Sulfasalazine and Sleep Disorder Due To A General Medical Condition for Men aged 40-49 - 14 seconds ago
- Sulfasalazine and Sleep Disorder for Men aged 40-49 - 14 seconds ago
- Depression and Urine Osmolarity Decreased - 18 seconds ago